Joint Final Report of EORTC 26951 and RTOG 9402: Phase III Trials with Procarbazine, Lomustine, and Vincristine Chemotherapy for Anaplastic Oligodendroglial Tumors

Andrew B. Lassman, Khê Hoang-Xuan, Mei Yin C. Polley, Alba A. Brandes, J. Gregory Cairncross, Johan M. Kros, Lynn S. Ashby, Martin J.B. Taphoorn, Luis Souhami, Winand N.M. Dinjens, Nadia N. Laack, Mathilde C.M. Kouwenhoven, Karen L. Fink, Pim J. French, David R. Macdonald, Denis Lacombe, Minhee Won, Thierry Gorlia, Minesh P. Mehta, Martin J. Van Den Bent

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of 'Joint Final Report of EORTC 26951 and RTOG 9402: Phase III Trials with Procarbazine, Lomustine, and Vincristine Chemotherapy for Anaplastic Oligodendroglial Tumors'. Together they form a unique fingerprint.

Medicine & Life Sciences